{
  "Cluster": "7",
  "CandidateSubtype": "mixed",
  "TopGenes": [
    "MYH7B",
    "MATN3",
    "APCDD1",
    "CHGB",
    "ROBO1",
    "NKD1",
    "NRP2",
    "BMP4",
    "GNAS",
    "PLAT",
    "TMX4",
    "ZNRF3",
    "PTN",
    "ITGA8",
    "TGFB2",
    "CTSH",
    "SERPINI1",
    "BGN",
    "ZNF503",
    "LAMC1"
  ],
  "ProliferationScore": "0.080 (low)",
  "StemnessScore": "0.751 (high)",
  "ImmuneScore": "0.182 (low)",
  "PrognosticScore": "0.000 (low)",
  "SupportingEvidence": [
    "Strong mesenchymal/ECM program (MATN3, BGN, LAMC1, ITGA8, PLAT) and TGFB2 suggesting EMT and stromal differentiation",
    "Wnt/\u03b2-catenin feedback targets (APCDD1, NKD1, ZNRF3) consistent with canonical HB signaling",
    "Developmental/morphogenetic factors (BMP4, PTN) and guidance receptors (ROBO1, NRP2) typical of progenitor-like mixed epithelial\u2013mesenchymal states",
    "Divergent differentiation signals (MYH7B muscle, CHGB/SERPINI1 neuroendocrine/neuronal) argue against purely fetal or embryonal epithelial identity"
  ],
  "SuggestedExperiments": [
    "IHC/IF for epithelial (EPCAM, KRT8/18) and mesenchymal/chondroid markers (VIM, MATN3, SOX9, COL2A1)",
    "\u03b2-catenin localization (nuclear IHC) and Wnt target readouts (AXIN2, GLUL, APCDD1/NKD1 by qPCR/ISH)",
    "Assess TGF-\u03b2 activity (pSMAD2/3 IHC) and ECM deposition (LAMC1, BGN)",
    "Evaluate ROBO1/NRP2 and angiogenesis markers (CD34) spatially",
    "Functional assays: tumorsphere formation and migration/invasion to confirm progenitor/EMT features"
  ]
}